These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 35901657)

  • 1. Prescription trends in anti-seizure medications for adult patients with epilepsy in Japan: A retrospective cohort study using the database of health insurance claims between 2015 and 2019.
    Jin K; Obara T; Hirano K; Hirai D; Kiuchi M; Tanaka T; Nakasato N
    Epilepsy Behav; 2022 Sep; 134():108841. PubMed ID: 35901657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: A German longitudinal analysis from 2008 to 2020.
    Hochbaum M; Kienitz R; Rosenow F; Schulz J; Habermehl L; Langenbruch L; Kovac S; Knake S; von Podewils F; von Brauchitsch S; Hamacher M; Strzelczyk A; Willems LM
    Epilepsy Behav; 2022 May; 130():108666. PubMed ID: 35339390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of mental health conditions by seizure control among adults with epilepsy in the United States.
    Schabert VF; Stern S; Ferrari L; Wade CT; Willke RJ; Hauser WA
    Epilepsy Behav; 2022 Sep; 134():108865. PubMed ID: 35952507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy.
    Kim H; Faught E; Thurman DJ; Fishman J; Kalilani L
    JAMA Neurol; 2019 Jul; 76(7):783-790. PubMed ID: 30933252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends of anti-seizure medication use in pediatric patients in six cities in China from 2013 to 2018.
    Yu L; Feng J; Yu Z; Dai H
    Epilepsy Res; 2020 Nov; 167():106448. PubMed ID: 32916644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the prescription of anti-seizure medicines for pregnant women outpatients with epilepsy during 2016-2020 in Japan.
    Kikuchi D; Obara T; Miura R; Suzuki N; Josaka R; Tokunaga M; Ouchi R; Usui K; Okada K
    Seizure; 2022 May; 98():101-104. PubMed ID: 35462299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in prescription of anti-seizure medicines for Japanese pediatric outpatients during 2013-2019.
    Kikuchi D; Obara T; Kashiwagura S; Arima Y; Hino H; Miura R; Hayakawa S; Watanabe Y
    Epilepsy Behav Rep; 2021; 16():100474. PubMed ID: 34458714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of trends and factors determining initial antiseizure medication choice for epilepsy in Taiwan.
    Chiang KL; Liang CY; Hsieh LP; Chien LN
    Seizure; 2021 Dec; 93():145-153. PubMed ID: 34768177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of Antiseizure Medications in Women of Childbearing Age With Epilepsy and Nonepilepsy Indications: A Retrospective Cohort Study.
    Lawal OD; Meador KJ; Hume AL; Wen X
    Neurology; 2023 Sep; 101(10):e1083-e1096. PubMed ID: 37407266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Greater need for treatment optimization in patients with epilepsy initiating adjunctive therapy: Results of a retrospective claims analysis of antiseizure medication drug load in the United States.
    Connor GS; Labiner DM; Schabert VF; Weingarten M; Wade CT; Stern S; Becker DA
    Epilepsy Behav; 2024 Mar; 152():109649. PubMed ID: 38277849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world analysis of retention on cenobamate in patients with epilepsy in the United States.
    Stern S; Weingarten M; Mandapati S; Ferrari L; Wade CT
    Epilepsy Res; 2023 Nov; 197():107207. PubMed ID: 37741165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the efficacy of anti-seizure medications using matched cohorts on a large insurance claims database.
    Kan-Tor Y; Ness L; Szlak L; Benninger F; Ravid S; Chorev M; Rosen-Zvi M; Shimoni Y; Fisher RS
    Epilepsy Res; 2024 Mar; 201():107313. PubMed ID: 38417192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to and persistence with lacosamide, perampanel, lamotrigine, and levetiracetam in adult patients with focal epilepsy in Japan: A descriptive cohort study using a claims database.
    Chen S; Fukasawa T; Ikeda A; Takeuchi M; Shimotake A; Yoshida S; Kawakami K
    Heliyon; 2023 Apr; 9(4):e15017. PubMed ID: 37064469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shift from older- to newer-generation antiseizure medications in people with acute ischemic stroke in Australia: A population-based study.
    Kim SJ; Wood S; Marquina C; Foster E; Bell JS; Ilomäki J
    Epilepsia Open; 2023 Dec; 8(4):1413-1424. PubMed ID: 37574594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-seizure Medication Prescription in Adult Outpatients With Epilepsy in China, 2013-2018.
    Yu L; Zhu W; Zhu X; Lu Y; Yu Z; Dai H
    Front Neurol; 2021; 12():649589. PubMed ID: 34108928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in prescription of anti-seizure medications in Japan between 2018 and 2021: A retrospective study using the National Database Open Data Japan.
    Ura H; Matsuoka N; Kubota K; Sadamoto K
    Epilepsy Behav; 2024 Oct; 159():109949. PubMed ID: 39121754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-seizure medication prescription in epilepsy patients in South Korea: A seven-year population-based retrospective cohort study.
    Jang Y; Lee HS; Kim MS; Lee J; Jung KY
    Seizure; 2023 Jul; 109():70-76. PubMed ID: 37267669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between anti-seizure medication and the risk of lower urinary tract infection in patients with epilepsy.
    Gremke N; Printz M; Möller L; Ehrenberg C; Kostev K; Kalder M
    Epilepsy Behav; 2022 Oct; 135():108910. PubMed ID: 36115082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of antiseizure medication use and cost in the United States of America 2006-2021.
    Sánchez Fernández I; Gaínza-Lein M; Amengual-Gual M; Barcia Aguilar C; Romeu A; Torres A; Jonas R; Douglass LM
    Seizure; 2023 Nov; 112():128-138. PubMed ID: 37832279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.